Clinical Trials Browser

Phase 2 × Completed × Biliary Cancer Metastatic × Clear all

NCT03464968 2020-12-02

mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line

Phase 2 Completed

Gastrointestinal

Biliary Cancer Metastatic